Elsevier

Gender Medicine

Volume 5, Issue 1, March 2008, Pages 24-35
Gender Medicine

Gender differences in methamphetamine use and responses: A review

https://doi.org/10.1016/S1550-8579(08)80005-8Get rights and content

Abstract

Background: Men and women differ markedly with regard to their use of, and responses to, methamphetamine (MA) and related amphetamines. However, these gender differences oftentimes are given only a cursory consideration in the analyses of these MA effects.

Objective: In this brief review, we summarize the data on gender differences in various parameters of MA use and responses. Such information on the pattern of male versus female differences in the use and responses to this psychostimulant can aid in tailoring gender-dependent treatment strategies.

Methods: English-language articles were identified from MEDLINE as well as from reference lists of identified articles for the years 1966 to 2007. Search terms included various combinations of men/male, women/female, methamphetamine, and gender/sex differences. Only studies with human subjects were reviewed.

Results: Women tend to begin MA use at earlier ages, appear more dependent on MA, but also respond better to treatment than do men. MA use appears to be associated with depression in women, and women seem more committed to MA, whereas men are more likely to use other drugs in the absence of access to MA. Female MA abusers had both larger volumes within the corpus callosum and more hyperperfused regions in the parietal and occipital areas of the brain, along with more genetic alterations but less MA-induced toxicity. Amphetamine-stimulated dopamine release was greater in men.

Conclusions: When considered in total, women seem more dependent on and committed to MA but show diminished (amphetamine-stimulated) dopamine responses and a decreased degree of toxicity, as indicated by a lower incidence of emergency department-related deaths involving MA. A pervasive comorbidity of depression or depression-related characteristics were present in women MA users, suggesting that MA may serve as a type of self-medication for their depression. These findings not only highlight the need for consideration of gender when assessing MA use, but also can serve to direct efforts at prevention and treatment programs that address the specific needs of men and women.

References (54)

  • SC Bae et al.

    Increased white matter hyperintensities in male methamphetamine abusers

    Drug Alcohol Depend

    (2006)
  • CA Munro et al.

    Sex differences in striatal dopamine release in healthy adults

    Biol Psychiatry

    (2006)
  • KK Yeo et al.

    The association of methamphetamine use and cardiomyopathy in young patients

    Am J Med

    (2007)
  • JW Wright et al.

    Important role for angiotensin III and IV in the brain renin-angiotensin system

    Brain Res Rev

    (1997)
  • DE Dluzen

    Estrogen, testosterone and gender differences

    Endocrine

    (2005)
  • B Liu et al.

    Gender differences in methamphetamine effects: Review of animal and human studies

  • SK Lin et al.

    Psychiatric comorbidity and gender differences of persons incarcerated for methamphetamine abuse in Taiwan

    Psychiatry Clin Neurosci

    (2004)
  • J Westermeyer et al.

    Course, severity, and treatment of substance abuse among women versus men

    Am J Drug Alcohol Abuse

    (2000)
  • National Institute of Justice
  • JY Kim et al.

    Gender differences in juvenile arrestees' drug use, self-reported dependence and perceived need for treatment

    Psychiatr Serv

    (2002)
  • LA Goldsamt et al.

    The relationship between club drug use and other drug use: A survey of New York City middle school students

    Subst Use Misuse

    (2005)
  • S Strauss et al.

    Women offenders who use and deal methamphetamine: Implications for mandated drug treatment

    Women Crim Just

    (2001)
  • SJ Semple et al.

    Female methamphetamine users: Social characteristics and sexual risk behavior

    Women Health

    (2004)
  • JE Zweben et al.

    for the Methamphetamine Treatment Project. Psychiatric symptoms in methamphetamine users

    Am J Addict

    (2004)
  • SR Senjo

    Trafficking in meth: An analysis of the differences between male and female dealers

    J Drug Educ

    (2005)
  • JB Cohen et al.

    for the Methamphetamine Treatment Project. Abuse and violence history of men and women in treatment for methamphetamine dependence

    Am J Addict

    (2003)
  • SL Batki et al.

    Quantitative drug levels in stimulant psychosis: Relationship to symptom severity, catecholamines and hyperkinesia

    Am J Addict

    (2004)
  • Cited by (184)

    View all citing articles on Scopus
    View full text